Drugs / WO533
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04222647 | Jan → Aug 2020 | postmenopausal atrophic vaginitis | Dr. August Wolff GmbH & Co. KG Arzneimittel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WO533 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04222647 ↗ |
| Route | Other | “Intravaginal application” NCT04222647 ↗ |